Steroids and Steroid Receptors in Low Back Pain
Steroids and Steroid Receptors in Low Back Pain
批准号:
9976979
负责人:
Jun-Ming Zhang
金额:
$34.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-15 至 2022-06-30
关键词:
Adrenal Cortex HormonesAfferent NeuronsAgonistAldosteroneAnti-Inflammatory AgentsAntiinflammatory EffectBack PainBrainCardiac MyocytesCell LineChronicChronic low back painClinicalClinical TreatmentClinical TrialsCorticosteroneCountryDevelopmentDexamethasoneGlucocorticoid ReceptorGlucocorticoidsGoalsHealth Care CostsHeart failureHumanHydrocortisoneHypertensionImmune responseImmune systemIn VitroInflammationInflammatoryInflammatory ResponseInjectionsKidneyLaboratoriesLow Back PainMeasuresMedical Care CostsMethodsMethylprednisoloneMineralocorticoid ReceptorMineralocorticoidsModelingMolecularNeurogliaNeuronsPainPain managementPatientsPeripheralPharmaceutical PreparationsPlayPre-Clinical ModelProductivityRandomized Clinical TrialsRattusReagentReceptor ActivationRoleSecondary toSlipped DiskSodiumSpinal GangliaSteroid ReceptorsSteroidsTechniquesTestingTissuesTriamcinoloneUnited StatesWagesWorkcell typechronic painchronic pain reliefchronic painful conditioncommon treatmentcost estimatecytokinedisabilityeplerenoneimprovedknock-downmacrophagenovel therapeutic interventionnucleus pulposuspain behaviorpain modelpain reductionpotency testingpre-clinicalreceptorresponsesocietal costswound healing
中文摘要
腰痛是一种常见的疾病,会使人虚弱,在30%的病例中会变成慢性疾病。
英文摘要
Low back pain is a common ailment which can be debilitating and which becomes chronic in 30% of cases.
Many patients fail to achieve adequate relief for such chronic pain conditions with current therapies.
Inflammation of the lumbar dorsal root ganglia (DRG), e.g. secondary to an immune response to a ruptured
disc, may contribute to some forms of low back pain. Because inflammation plays an important role in back
pain, a common treatment involves local injections of anti-inflammatory corticosteroids. However, this
treatment has been controversial. Randomized clinical trials of these treatments have had mixed results, and
not all patients obtain relief from steroids. The nominal target of corticosteroid drugs is the glucocorticoid
receptor (GR). However, recent in vitro studies show that many steroids clinically used for back pain injections
(including 6-α methylprednisolone and triamcinolone) can also activate the mineralocorticoid receptor (MR)
with similar potency. The MR is best known as the target of aldosterone, promoting sodium reabsorption in the
kidney. However, this receptor is expressed in other cell types including cardiomyocytes, brain neurons, and
DRG neurons. In many tissues MR plays a pro-inflammatory role which would be expected to counteract the
anti-inflammatory effects of GR activation. Our hypothesis is that avoiding MR activation will increase the
efficacy of steroids used in treatment of low back pain. We will test this hypothesis with three specific aims
(SA), using two established preclinical models of low back pain. SA1. To further characterize effects of local
MR activation in contributing to back pain and molecular correlates of inflammation. We will determine the
effects of local mineralocorticoid blockade or activation, and MR receptor knockdown, in rat models of low back
pain, examining pain behaviors, sensory neuron excitability, cytokine profile, and histochemical measures of
inflammation and receptor activation. SA2. To test the hypothesis that clinically used glucocorticoids (GR
agonists) also activate the mineralocorticoid receptor, reducing their ability to improve back pain and molecular
correlates of inflammation. We will examine the effects of several steroids commonly used in low back pain
injections (all of which activate the MR in vitro), a highly glucocorticoid selective steroid used in in other clinical
settings, and the endogenous glucocorticoid corticosterone. SA3. To assess a novel therapeutic approach for
back pain by combining GR agonists with MR antagonists to improve back pain and molecular correlates of
inflammation. The steroids examined in SA2 will be tested in combination with mineralocorticoid antagonists or
knockdown. Our long term goal is to establish the preclinical basis for clinical trials testing our hypothesis that
mineralocorticoid antagonists may improve the response to locally injected steroids commonly used for low
back pain treatment. Such trials are made more feasible by the fact that a selective mineralocorticoid
antagonist, eplerenone, is already approved for use in the United States for heart failure and hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAIN
-
批准号:8013533
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
Neural and Chemical Basis of Pathological Pain
-
批准号:9203638
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAIN
-
批准号:7743572
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
Neural and Chemical Basis of Pathological Pain
-
批准号:8991249
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
Neural and Chemical Basis of Pathological Pain
-
批准号:8531395
-
项目类别:
-
资助金额:$41.96万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAIN
-
批准号:7373674
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAIN
-
批准号:8197025
-
项目类别:
-
资助金额:$33.44万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
NEURAL AND CHEMICAL BASIS OF PATHOLOGIC PAIN
-
批准号:7537162
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
Neural and Chemical Basis of Pathological Pain
-
批准号:8628191
-
项目类别:
-
资助金额:$39.09万
-
财政年份:2007
-
负责人:Jun-Ming Zhang
-
依托单位:
Study of Activity Dependent Sympathetic Sprouting
-
批准号:9208801
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2005
-
负责人:Jun-Ming Zhang
-
依托单位:
Study of Activity Dependent Sympathetic Sprouting
-
批准号:9812454
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2005
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:7054238
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:7225570
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:8443828
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:7991735
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:6819366
-
项目类别:
-
资助金额:$28.5万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:8243574
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:8656153
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
STUDY OF ACTIVITY-DEPENDENT SYMPATHETIC SPROUTING
-
批准号:8064701
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
Study of Activity-Dependent Sympathetic Sprouting
-
批准号:10445332
-
项目类别:
-
资助金额:$53.53万
-
财政年份:2004
-
负责人:Jun-Ming Zhang
-
依托单位:
海外基金